However, tyrosine kinases, particularly Janus kinase 2 (JAK2), have been linked to myeloproliferative diseases other than chronic myeloid leukemia [113]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.